Biochemical Pharmacist Course

Lesson 1 • Signal Transduction Pathways

Introduces receptor-mediated signaling cascades and second messengers. Connects cellular communication to receptor-targeted pharmacology.

Lesson 2 • Amino Acids, Proteins, and Enzymes

Examines protein structure levels and enzyme catalysis mechanisms. Provides the basis for understanding enzyme-targeted drugs.

Lesson 3 • Nucleic Acids and Gene Expression

Explains DNA replication, transcription, and translation processes. Supports understanding of drugs targeting nucleic acid synthesis.

Lesson 4 • Carbohydrate and Lipid Biochemistry

Covers glycolysis, lipid metabolism, and energy production pathways. Links metabolic disruptions to pharmacological intervention points.

Lesson 1 • Renal and Biliary Drug Excretion

Covers glomerular filtration, tubular secretion, and biliary elimination. Connects renal function to dose adjustment requirements.

Lesson 2 • Drug Distribution in the Body

Examines volume of distribution, plasma protein binding, and tissue partitioning. Links physicochemical drug properties to distribution patterns.

Lesson 3 • Compartmental Pharmacokinetic Modeling

Introduces one- and two-compartment models and key PK parameters. Enables calculation of half-life, clearance, and steady-state concentrations.

Lesson 4 • Drug Absorption Mechanisms

Covers passive diffusion, active transport, and bioavailability factors. Establishes how route of administration affects drug entry into systemic circulation.

Lesson 1 • Receptor Regulation and Tolerance

Explains receptor upregulation, downregulation, and desensitization mechanisms. Links chronic drug exposure to tolerance and withdrawal phenomena.

Lesson 2 • Therapeutic Index and Safety Margins

Defines therapeutic index, safety margin, and selectivity ratios. Applies these parameters to risk-benefit assessment in drug therapy.

Lesson 3 • Drug Interactions at the Receptor Level

Covers competitive, noncompetitive, and allosteric interactions between drugs. Prepares students to predict and manage pharmacodynamic drug interactions.

Lesson 4 • Dose-Response Relationships

Examines graded and quantal dose-response curves and their parameters. Connects potency and efficacy measurements to clinical drug selection.

Lesson 1 • Ion Channel Modulation by Drugs

Examines voltage-gated and ligand-gated channel pharmacology. Links channel blockade or activation to cardiovascular and neurological drug effects.

Lesson 2 • Transporter Proteins as Drug Targets

Covers neurotransmitter reuptake transporters and ABC transporter pharmacology. Explains how transporter inhibition or induction alters drug and neurotransmitter levels.

Lesson 3 • Enzyme Inhibition as Drug Mechanism

Covers competitive, irreversible, and suicide inhibition with clinical examples. Connects inhibitor kinetics to therapeutic and toxic outcomes.

Lesson 4 • Nucleic Acid-Targeted Drug Mechanisms

Examines intercalation, alkylation, and topoisomerase inhibition strategies. Connects DNA-targeting mechanisms to antineoplastic and antimicrobial drug classes.

Lesson 1 • Cytochrome P450 System in Depth

Covers CYP isoform specificity, induction, and inhibition with clinical relevance. Enables prediction of metabolic drug-drug interactions.

Lesson 2 • Prodrug Activation and Bioactivation

Covers enzymatic conversion of prodrugs to active forms and toxic bioactivation. Connects prodrug design to improved bioavailability and targeted delivery.

Lesson 3 • Genetic Polymorphisms in Drug Metabolism

Examines poor, intermediate, extensive, and ultrarapid metabolizer phenotypes. Applies pharmacogenomic data to individualized dosing strategies.

Lesson 4 • Phase II Conjugation Reactions

Examines glucuronidation, sulfation, acetylation, and glutathione conjugation. Links conjugation capacity to individual variability in drug clearance.

Lesson 1 • Immunological Drug Reactions

Covers hapten formation, immune sensitization, and hypersensitivity reaction types. Explains the biochemical basis of allergic and idiosyncratic drug reactions.

Lesson 2 • Reactive Metabolites and Oxidative Stress

Covers reactive oxygen species generation, lipid peroxidation, and antioxidant defense. Links oxidative stress to hepatotoxicity and nephrotoxicity mechanisms.

Lesson 3 • Toxicokinetics and Dose-Toxicity Relationships

Covers toxicokinetic modeling, threshold doses, and nonlinear toxicity responses. Connects exposure metrics to risk assessment in clinical practice.

Lesson 4 • Genotoxicity and Carcinogenicity

Examines DNA adduct formation, mutagenesis, and carcinogen activation pathways. Applies genotoxicity testing principles to drug safety evaluation.

Lesson 1 • Anti-Infective Drug Biochemistry

Covers antibacterial, antiviral, antifungal, and antiparasitic mechanisms of action. Connects pathogen-specific biochemical targets to selective toxicity principles.

Lesson 2 • Cardiovascular and Metabolic Drug Biochemistry

Covers statins, antihypertensives, antidiabetics, and antithrombotics at the molecular level. Links lipid, glucose, and coagulation biochemistry to drug targets.

Lesson 3 • Anticancer Drug Mechanisms

Examines cytotoxic agents, targeted kinase inhibitors, and immunotherapy biochemistry. Links tumor cell biology to drug selectivity and resistance mechanisms.

Lesson 4 • Neuropsychiatric Drug Mechanisms

Examines antidepressants, antipsychotics, anxiolytics, and analgesics at the receptor level. Connects neurotransmitter biochemistry to psychopharmacological drug action.

Lesson 1 • Outcomes Evaluation and Pharmacovigilance

Covers adverse drug reaction reporting, outcomes measurement, and safety surveillance. Connects biochemical toxicity knowledge to real-world pharmacovigilance practice.

Lesson 2 • Therapeutic Drug Monitoring Principles

Covers target concentration ranges, sampling strategies, and assay interpretation. Applies TDM to narrow-therapeutic-index drugs in clinical settings.

Lesson 3 • Pharmacogenomics in Clinical Practice

Examines genotype-guided prescribing, biomarker testing, and clinical decision support. Connects genetic variation to individualized drug selection and dosing.

Lesson 4 • Dosing in Special Populations

Examines pediatric, geriatric, renal, and hepatic impairment dosing adjustments. Applies physiological differences to pharmacokinetic parameter modification.